Quantitative Systematic Strategies’s Novartis NVS Stock Holding History

Quantitative Systematic Strategies’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-15,634	Closed	-$1.36M	–	679
2020 Q2	$1.36M	Buy	15,634 +2,699	+21%	+$233K	0.27%	124
2020 Q1	$1.07M	Buy	+12,935	New	+$1.15M	0.87%	17
2019 Q4	–	Sell	-16,260	Closed	-$1.41M	–	621
2019 Q3	$1.41M	Sell	16,260 -22,130	-58%	-$1.99M	0.32%	95
2019 Q2	$3.5M	Buy	+38,390	New	+$3.25M	0.66%	35
2018 Q2	–	Sell	-10,253	Closed	-$743K	–	741
2018 Q1	$743K	Buy	+10,253	New	+$781K	0.16%	214
2017 Q2	–	Sell	-4,039	Closed	-$269K	–	494
2017 Q1	$269K	Buy	+4,039	New	+$269K	0.08%	277
2016 Q1	–	Sell	-3,858	Closed	-$302K	–	650
2015 Q4	$302K	Buy	+3,858	New	+$306K	0.08%	690

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Quantitative Systematic Strategies's NVS Position: Q3 2020 in Review

Quantitative Systematic Strategies sold out of Novartis (NVS) in Q3 2020, closing a stake of 15,634 shares — an estimated $1.36M sold.

Quantitative Systematic Strategies first reported a position in NVS in Q4 2015 and held it in 7 quarters. The position peaked at $3.5M in Q2 2019. 1,118 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

Quantitative Systematic Strategies reported no remaining Novartis position as of Q3 2020 after selling out during the quarter.
Quantitative Systematic Strategies sold 15,634 Novartis shares in Q3 2020, an estimated $1.36M.
Quantitative Systematic Strategies first reported a position in Novartis in Q4 2015 and held it in 7 quarters.
Quantitative Systematic Strategies's Novartis position peaked at $3.5M in Q2 2019.
1,118 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2020, filed 9 Nov 2020.